PRICE T ROWE ASSOCIATES INC /MD/ - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$35,000
-52.1%
128,9000.0%0.00%
Q2 2022$73,000
-14.1%
128,9000.0%0.00%
Q1 2022$85,000
-48.8%
128,900
-16.7%
0.00%
Q4 2021$166,000
+18.6%
154,700
+43.9%
0.00%
Q3 2021$140,000
-34.6%
107,5000.0%0.00%
Q2 2021$214,000
-26.2%
107,5000.0%0.00%
Q1 2021$290,000107,5000.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders